{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:37:28Z","timestamp":1791823048871,"version":"4.3.4"},"reference-count":23,"publisher":"Baishideng Publishing Group Inc.","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.1613","type":"journal-article","created":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T05:32:32Z","timestamp":1238736752000},"page":"1613","source":"Crossref","is-referenced-by-count":112,"title":["Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial"],"prefix":"10.3748","volume":"15","author":[{"given":"Binay Krishna","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhabrata","family":"Gangopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanta Das","family":"Baksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adyapad","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramit","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005;9:37-53.","DOI":"10.1016\/j.cld.2004.11.001"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Teli MR, Day CP, Burt AD, Bennett MK, James OF. Lancet 1995;346:987-990.","DOI":"10.1016\/S0140-6736(95)91685-7"},{"key":"ref3","unstructured":"Perrot S, Beaugrand M. [Treatment of alcoholic hepatitis. A review of randomized trials]. Gastroenterol Clin Biol 1988;12:521-531."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Stewart S, Jones D, Day CP. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med 2001;7:408-413.","DOI":"10.1016\/S1471-4914(01)02096-2"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Zhang T, Li Y, Lai JP, Douglas SD, Metzger DS, O'Brien CP, Ho WZ. Alcohol potentiates hepatitis C virus replicon expression. Hepatology 2003;38:57-65.","DOI":"10.1053\/jhep.2003.50295"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Ji C. Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. J Gastroenterol Hepatol 2008;23 Suppl 1:S16-S24.","DOI":"10.1111\/j.1440-1746.2007.05276.x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Degoul F, Sutton A, Mansouri A, Cepanec C, Degott C, Fromenty B, Beaugrand M, Valla D, Pessayre D. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 2001;120:1468-1474.","DOI":"10.1053\/gast.2001.24051"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Latvala J, Hietala J, Koivisto H, J&auml;rvi K, Anttila P, Niemel&auml; O. Immune Responses to Ethanol Metabolites and Cytokine Profiles Differentiate Alcoholics with or without Liver Disease. Am J Gastroenterol 2005;100:1303-1310.","DOI":"10.1111\/j.1572-0241.2005.41509.x"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Spahr L, Giostra E, Frossard JL, Bresson-Hadni S, Rubbia-Brandt L, Hadengue A. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol 2004;41:229-234.","DOI":"10.1016\/j.jhep.2004.04.028"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022-2036.","DOI":"10.1111\/j.1572-0241.1998.00587.x"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-199.","DOI":"10.1016\/0016-5085(78)90401-8"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, Malinchoc M, Kamath PS, Shah V. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005;41:353-358.","DOI":"10.1002\/hep.20503"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Forrest EH, Morris AJ, Stewart S, Phillips M, Oo YH, Fisher NC, Haydon G, O'Grady J, Day CP. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut 2007;56:1743-1746.","DOI":"10.1136\/gut.2006.099226"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Christensen E. Alcoholic hepatitis--glucocorticosteroids or not? J Hepatol 2002;36:547-548.","DOI":"10.1016\/S0168-8278(02)00045-4"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Agarwal K, Kontorinis N, Kontorinis N, Dieterich DT, Dieterich DT. Alcoholic Hepatitis. Curr Treat Options Gastroenterol 2004;7:451-458.","DOI":"10.1007\/s11938-004-0004-6"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Levitsky J, Mailliard ME. Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 2004;24:233-247.","DOI":"10.1055\/s-2004-832937"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Haber PS, Warner R, Seth D, Gorrell MD, McCaughan GW. Pathogenesis and management of alcoholic hepatitis. J Gastroenterol Hepatol 2003;18:1332-1344.","DOI":"10.1046\/j.1440-1746.2003.03217.x"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Raetsch C, Jia JD, Boigk G, Bauer M, Hahn EG, Riecken EO, Schuppan D. Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut 2002;50:241-247.","DOI":"10.1136\/gut.50.2.241"},{"key":"ref19","unstructured":"Savolainen VT, Liesto K, M&auml;nnikk&ouml; A, Penttil&auml; A, Karhunen PJ. Alcohol Consumption and Alcoholic Liver Disease: Evidence of a Threshold Level of Effects of Ethanol. Alcohol Clin Exp Res 2007;17:1112-1117."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Reuben A. Alcohol and the liver. Curr Opin Gastroenterol 2008;24:328-338.","DOI":"10.1097\/MOG.0b013e3282fbceca"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, Reiser J, Kolls JK. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 2008;181:3049-3056.","DOI":"10.4049\/jimmunol.181.5.3049"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Lee KS, Cottam HB, Houglum K, Wasson DB, Carson D, Chojkier M. Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity. Am J Physiol 1997;273:G1094-G1100.","DOI":"10.1152\/ajpgi.1997.273.5.G1094"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Windmeier C, Gressner AM. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmacol 1997;29:181-196.","DOI":"10.1016\/S0306-3623(96)00314-X"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i13\/1613.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T09:01:19Z","timestamp":1558256479000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i13\/1613.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.1613","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}